Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleState of the Art

Functional Imaging of Chemobrain: Usefulness of Nuclear Medicine in the Fog Coming After Cancer

Agostino Chiaravalloti, Luca Filippi, Marco Pagani and Orazio Schillaci
Journal of Nuclear Medicine April 2023, 64 (4) 508-514; DOI: https://doi.org/10.2967/jnumed.121.263294
Agostino Chiaravalloti
1Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy;
2IRCCS Neuromed, Pozzilli, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luca Filippi
3Nuclear Medicine Section, Santa Maria Goretti Hospital, Latina, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Pagani
4Institute of Cognitive Sciences and Technologies, Consiglio Nazionale Delle Ricerche, Rome, Italy; and
5Department of Medical Radiation Physics and Nuclear Medicine, Karolinska Hospital, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Orazio Schillaci
1Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 64 no. 4 508-514
DOI 
https://doi.org/10.2967/jnumed.121.263294
PubMed 
36732056

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication May 14, 2022
  • Revision received January 26, 2023
  • Published online April 3, 2023.

Article Versions

  • previous version (February 2, 2023 - 12:06).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Agostino Chiaravalloti*,1,2,
  2. Luca Filippi*,3,
  3. Marco Pagani†,4,5 and
  4. Orazio Schillaci†,1
  1. 1Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy;
  2. 2IRCCS Neuromed, Pozzilli, Italy;
  3. 3Nuclear Medicine Section, Santa Maria Goretti Hospital, Latina, Italy;
  4. 4Institute of Cognitive Sciences and Technologies, Consiglio Nazionale Delle Ricerche, Rome, Italy; and
  5. 5Department of Medical Radiation Physics and Nuclear Medicine, Karolinska Hospital, Stockholm, Sweden
  1. For correspondence or reprints, contact Agostino Chiaravalloti (agostino.chiaravalloti{at}uniroma2.it).
  1. ↵* Contributed equally to this work.

  2. ↵† Contributed equally to this work.

View Full Text

Statistics from Altmetric.com

Cited By...

  • 2 Citations
  • 3 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer
    Senbang Yao, Qianqian Zhang, Xinxin Yao, Xiuqing Zhang, Lulian Pang, Sheng Yu, Huaidong Cheng
    Breast Cancer Research and Treatment 2023 201 1
  • Development of a Novel 99mTc-Labeled Folate Derivative Containing Phenyl Isonitrile to Target Folate Receptor with Reduced Renal Uptake
    Junhong Feng, Xuran Zhang, Yuhao Jiang, Qianna Wang, Qing Ruan, Guangxing Yin, Penwen Han, Jin Du, Junbo Zhang
    Molecular Pharmaceutics 2024 21 11
  • Seeing through “brain fog”: neuroimaging assessment and imaging biomarkers for cancer-related cognitive impairments
    Quanquan Gu, Liya Wang, Tricia Z. King, Hongbo Chen, Longjiang Zhang, Jianming Ni, Hui Mao
    Cancer Imaging 2024 24 1

Article usage

Article usage: February 2023 to April 2025

AbstractFullPdf
Feb 20233345075
Mar 20232260080
Apr 202319098585
May 20235542619
Jun 2023382167
Jul 2023417118
Aug 20235071415
Sep 20234101124
Oct 20237114241
Nov 20235714139
Dec 20233813746
Jan 20244023858
Feb 20244123341
Mar 20243118457
Apr 20244910157
May 2024359142
Jun 2024478340
Jul 202410312852
Aug 202410710762
Sep 2024289953
Oct 20242818277
Nov 20242213560
Dec 20242411051
Jan 20251712556
Feb 20252516136
Mar 20251312439
Apr 20252616449
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (4)
Journal of Nuclear Medicine
Vol. 64, Issue 4
April 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Functional Imaging of Chemobrain: Usefulness of Nuclear Medicine in the Fog Coming After Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Functional Imaging of Chemobrain: Usefulness of Nuclear Medicine in the Fog Coming After Cancer
Agostino Chiaravalloti, Luca Filippi, Marco Pagani, Orazio Schillaci
Journal of Nuclear Medicine Apr 2023, 64 (4) 508-514; DOI: 10.2967/jnumed.121.263294

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Functional Imaging of Chemobrain: Usefulness of Nuclear Medicine in the Fog Coming After Cancer
Agostino Chiaravalloti, Luca Filippi, Marco Pagani, Orazio Schillaci
Journal of Nuclear Medicine Apr 2023, 64 (4) 508-514; DOI: 10.2967/jnumed.121.263294
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • CLINICAL FEATURES OF CRCI
    • CRCI PHYSIOPATHOLOGIC BASIS
    • SEARCH STRATEGY
    • RESULTS
    • CONCLUSIONS AND FUTURE OUTLOOK
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Quantitative Brain Amyloid PET
  • The Potential Contribution of Radiopharmaceutical Therapies in Managing Oligometastatic Disease
  • Sequencing of Somatostatin-Receptor–Based Therapies in Neuroendocrine Tumor Patients
Show more State of the Art

Similar Articles

Keywords

  • chemobrain
  • functional imaging
  • PET
  • FDG
  • DAT
  • neuroinflammation
SNMMI

© 2025 SNMMI

Powered by HighWire